All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Predictive Biomarkers in Breast Cancer: Their Value in Neoadjuvant Chemotherapy

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00179906%3A_____%2F12%3A10124867" target="_blank" >RIV/00179906:_____/12:10124867 - isvavai.cz</a>

  • Alternative codes found

    RIV/00216208:11150/12:10124867 RIV/00216208:11160/12:10124867

  • Result on the web

    <a href="http://informahealthcare.com/doi/full/10.3109/07357907.2012.725441" target="_blank" >http://informahealthcare.com/doi/full/10.3109/07357907.2012.725441</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.3109/07357907.2012.725441" target="_blank" >10.3109/07357907.2012.725441</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Predictive Biomarkers in Breast Cancer: Their Value in Neoadjuvant Chemotherapy

  • Original language description

    Neoadjuvant chemotherapy (NCT) of breast cancer enabled improved outcomes especially in patients with advanced and inflammatory diseases. Biological heterogeneity of these tumors, however, requires bettermolecular characterization of themalignant tissuewith consequent individualization in the selection of appropriate agents. To date, numerous molecular markers have been identified, and some of them (e.g., measurement of hormonal or growth factors receptors) are already routinely used for breast cancerclassification before NCT. In the present article, we summarize current knowledge about established as well as promising biomarkers which have demonstrated prognostic or predictive value in NCT of breast cancer.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FR - Pharmacology and apothecary chemistry

  • OECD FORD branch

Result continuities

  • Project

    <a href="/en/project/NS10373" target="_blank" >NS10373: Neoadjuvant chemoterapy in brest carcinoma</a><br>

  • Continuities

    P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Others

  • Publication year

    2012

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Cancer Investigation

  • ISSN

    0735-7907

  • e-ISSN

  • Volume of the periodical

    30

  • Issue of the periodical within the volume

    9

  • Country of publishing house

    US - UNITED STATES

  • Number of pages

    16

  • Pages from-to

    663-678

  • UT code for WoS article

    000309935600007

  • EID of the result in the Scopus database